VMD (Viemed Healthcare, Inc. Common Shares) Stock Analysis - News
Viemed Healthcare, Inc. Common Shares (VMD) is a publicly traded Healthcare sector company. As of May 21, 2026, VMD trades at $9.70 with a market cap of $369.57M and a P/E ratio of 25.52. VMD moved +0.88% today. Year to date, VMD is +33.33%; over the trailing twelve months it is +42.35%. Its 52-week range spans $5.93 to $10.18. Rallies surfaces VMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in VMD news today?
Viemed Healthcare FCF Jumps to $36.3M; Ventilator Revenue Drops to 46.9%: Viemed Healthcare’s first-quarter CFFO rose to $8.1 million from $2.9 million year-over-year, driving TTM FCF to $36.3 million versus $23.3 million at year-end 2025. Ventilator rentals fell to 46.9% of revenue from 54.4% while commercial payors and sleep and resupply segments grew to 23%, with PAP patients up 57%.
Moore Michael sold 65.00K (~$570.05K) on Mar 20, 2026.
Moore Michael sold 40.23K (~$370.54K) on Mar 19, 2026.
Moore Michael sold 31.57K (~$297.39K) on Mar 18, 2026.
VMD Analyst Consensus
VMD analyst coverage data. Average price target: $0.00.
Common questions about VMD
What changed in VMD news today?
Viemed Healthcare FCF Jumps to $36.3M; Ventilator Revenue Drops to 46.9%: Viemed Healthcare’s first-quarter CFFO rose to $8.1 million from $2.9 million year-over-year, driving TTM FCF to $36.3 million versus $23.3 million at year-end 2025. Ventilator rentals fell to 46.9% of revenue from 54.4% while commercial payors and sleep and resupply segments grew to 23%, with PAP patients up 57%.
Does Rallies summarize VMD news?
Yes. Rallies summarizes VMD news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is VMD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for VMD. It does not provide personalized investment advice.
